FDA Holds COVID-19 Briefing After Halting Johnson & Johnson Vaccine Over Clot Concerns

The Food and Drug Administration began holding a special COVID-19 briefing today at 10 a.m. after halting the Johnson & Johnson vaccine.

The FDA and CDC announced that a review of the vaccine is underway after six U.S. cases were reported of a rare and severe type of blood clot in individuals after receiving the immunization. 

White House COVID-19 Response Coordinator Jeff Zients said, "As FDA and CDC announced earlier today, out of an abundance of caution, they have recommended a pause in the use of the Johnson & Johnson vaccine as they review data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine. The FDA and CDC will be providing details at their briefing."

Listen to the LIVE Call below:

***As certain voices are censored and free speech platforms shut down, be sure to sign up for CBN News emails and the CBN News app to ensure you keep receiving news from a Christian Perspective.***